(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ALLO VIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ALLO VIR

ST13

US500000097799503

Class

5, 42

Filing

97799503

Registration

7396297

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

05/28/2024

Trademark type

Combined

Nice classes

5, 42

Filing date

02/17/2023

Registration date

05/28/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/28/2024

Last transaction

05/28/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/31/2023

First use in commerce

10/31/2023

Drawing code

3

Owner type

03

Owner location

Waltham, MA, US

Examiner

REGAN, JOHN B

Law office

M40

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the text "allo" above the text "vir" with the "o" in "allo" vertically aligned with the "v" in "vir"; the "o" in "allo" is partially surrounded by an arch bisected by a circle above which is a smaller arch partially surrounding the circle. The color gray is intended to show shading or contrast only.

Holders and representatives

Holders

Allovir, Inc.

Representatives

Maury M. Tepper, III TEPPER & EYSTER, PLLC

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

antiviral cell therapy products in the nature of virus-specific T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of virus-specific T cells; antiviral allogeneic cell therapy products in the nature of T cells; antiviral allogeneic cell therapy products in the nature of virus-specific T cells; antiviral cells for medical use; antiviral T cells for medical use; antiviral virus-specific T cells for medical use; antiviral immunotherapeutic agents for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agentsT cellsfor restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agentsallogenic T cellsfor restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agentsvirus-specific T cellsfor restoring viral immunity in immunocompromised patients

Class 42

Research and development in the pharmaceutical and biotechnology fields

Publications

History of USPTO decisions and trademark events.

31 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/28/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/28/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/12/2024

PUBO

PUBLISHED FOR OPPOSITION

03/12/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/21/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/21/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/06/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

01/09/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/09/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

01/09/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/09/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/19/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/19/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/19/2023

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

11/29/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/28/2023

GNRT

NON-FINAL ACTION E-MAILED

11/28/2023

CNRT

NON-FINAL ACTION WRITTEN

11/28/2023

IUAA

USE AMENDMENT ACCEPTED

11/28/2023

DOCK

ASSIGNED TO EXAMINER

11/16/2023

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

11/09/2023

IUAF

USE AMENDMENT FILED

11/09/2023

EAAU

TEAS AMENDMENT OF USE RECEIVED

11/07/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/23/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/23/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/23/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/23/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/23/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/08/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/07/2023

NWAP

NEW APPLICATION ENTERED

02/21/2023

Continuous trademark protection

Get notified about every new filing that threatens ALLO VIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.